Abstract
Liver disease, specifically cirrhosis, is a leading cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients. The diagnosis of early cirrhosis in HIV/hepatitis C virus (HCV)-coinfected patients may be challenging. The development of noninvasive methods for fibrosis assessment empowers the infectious disease specialist to diagnose advanced fibrosis or cirrhosis. Early diagnosis is essential to enroll patients in screening programs for esophageal varices and hepatocellular carcinoma. Cirrhosis may also modify decisions about treatment of both HIV and HCV, including vaccination, medications chosen, and referral for liver transplant. © 2013 The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Author supplied keywords
Cite
CITATION STYLE
Martel-Laferrière, V., Wong, M., & Dieterich, D. T. (2014). HIV/Hepatitis C Virus-coinfected patients and cirrhosis: How to diagnose it and what to do next? Clinical Infectious Diseases, 58(6), 840–847. https://doi.org/10.1093/cid/cit714
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.